title: Activity of the lipoxygenase inhibitor 1-phenyl-3-pyrazolidinone (phenidone) and derivatives on the inhibition of adhesion molecule expression on human umbilical vascular endothelial cells.
abstract: Leukocyte adhesion contributes to perfusion abnormalities and tissue damage during trauma, shock or overwhelming inflammation. This study was performed to determine whether the lipoxygenase inhibitor phenidone and derivatives decrease the expression of adhesion molecules on tumor necrosis factor-alpha (TNF-alpha) stimulated endothelial cells and attenuate leukocyte-endothelial interactions under flow in vitro. TNF-alpha stimulated human umbilical venous endothelial cells (HUVECs) were incubated with phenidone, 4-methyl-phenidone, 4-4-dimethyl-phenidone, 5-methyl-phenidone, 5-phenyl-phenidone, and 5-methyl-1,(2,5-di-chloro-phenyl)-3-pyrazolidone. We tested the inhibition of adhesion molecule expression at different inhibitor concentrations before, during, and after the stimulation of HUVECs. The inhibition of endothelial cell expression on HUVECs was measured by flow cytometry. Rolling and firm adhesion of leukocytes to pretreated endothelium was examined in a parallel plate flow chamber. Phenidone inhibited the expression of intercellular adhesion molecule-1, vascular cell adhesion molecule-1, and endothelial-leukocyte adhesion molecule-1 on HUVECs when added prior to HUVEC stimulation. The inhibitory effect of phenidone was still observed when added simultaneously, but not when added after HUVEC stimulation. 4-4-dimethyl-phenidone and 5-phenyl-phenidone inhibited the expression of adhesion molecules more effectively than phenidone. The attenuation of leukocyte rolling under flow conditions was also significantly more effective with 4-4-dimethyl-phenidone than with phenidone. Lipoxygenase inhibitors might be of therapeutically interest for the treatment of overwhelming systemic inflammation during shock, trauma, and sepsis.
authors.affiliation: Department of Anaesthesiology and Critical Care Medicine, Tuebingen University Hospital, Tuebingen, Germany.
authors.forename: Torsten Hans
authors.initials: TH
authors.lastname: Schroeder
authors.forename: Wolfgang Artur
authors.initials: WA
authors.lastname: Krueger
authors.forename: Hans-Jürgen
authors.initials: HJ
authors.lastname: Dieterich
authors.forename: Boris
authors.initials: B
authors.lastname: Nohé
references.citation: Shock. 2002 Sep;18(3):217-22
references.pmid: 12353921
references.citation: Nat Med. 2004 Sep;10(9):966-73
references.pmid: 15322539
references.citation: J Med Chem. 1991 May;34(5):1560-70
references.pmid: 1903450
references.citation: Life Sci. 1996 May 24;58(26):2377-87
references.pmid: 8691982
references.citation: Crit Care Med. 2000 Jul;28(7):2507-14
references.pmid: 10921586
references.citation: J Leukoc Biol. 1997 Jun;61(6):647-53
references.pmid: 9201255
references.citation: Int J Microcirc Clin Exp. 1993 Aug;13(1):13-26
references.pmid: 8262718
references.citation: FASEB J. 2000 Jan;14(1):48-54
references.pmid: 10627279
references.citation: Biol Neonate. 1999 Aug;76(2):84-91
references.pmid: 10393992
references.citation: Life Sci. 1996;58(23):2167-81
references.pmid: 8649201
references.citation: Arch Gerontol Geriatr. 2004 May-Jun;38(3):201-12
references.pmid: 15066307
references.citation: EMBO J. 1995 Aug 1;14(15):3731-40
references.pmid: 7641692
references.citation: Cardiovasc Res. 2003 Oct 15;60(1):49-57
references.pmid: 14522406
references.citation: J Biol Chem. 2004 Mar 5;279(10):9440-50
references.pmid: 14676201
references.citation: J Immunol. 1997 Apr 1;158(7):3401-7
references.pmid: 9120300
references.citation: Blood. 1997 Apr 15;89(8):3009-18
references.pmid: 9108422
references.citation: Shock. 1997 Jul;8(1):16-25
references.pmid: 9249908
references.citation: Anesth Analg. 2003 Jul;97(1):216-21, table of contents
references.pmid: 12818969
references.citation: N Engl J Med. 2004 Jan 1;350(1):4-7
references.pmid: 14702420
references.citation: Proc Natl Acad Sci U S A. 1998 Jun 23;95(13):7562-7
references.pmid: 9636189
references.citation: Trends Mol Med. 2003 Jun;9(6):263-8
references.pmid: 12829015
references.citation: J Biol Chem. 1995 Jan 13;270(2):933-43
references.pmid: 7822333
references.citation: J Biol Chem. 1998 Feb 20;273(8):4616-21
references.pmid: 9468519
references.citation: Chest. 1992 Jun;101(6):1644-55
references.pmid: 1303622
references.citation: Mol Cell Biol. 1994 Sep;14(9):5820-31
references.pmid: 7520526
references.citation: J Immunol. 1996 May 15;156(10):3961-9
references.pmid: 8621937
references.citation: J Biol Chem. 1995 Feb 24;270(8):3710-9
references.pmid: 7533155
references.citation: J Clin Invest. 1988 Mar;81(3):939-44
references.pmid: 3278007
references.citation: Intensive Care Med. 2004 Oct;30(10):1935-43
references.pmid: 15241586
references.citation: Acta Pharmacol Sin. 2004 May;25(5):672-7
references.pmid: 15132836
references.citation: Arterioscler Thromb Vasc Biol. 2005 Nov;25(11):2301-7
references.pmid: 16166569